HOME >> MEDICINE >> NEWS
2004 Salivary Research Award to Ekstrom

Honolulu, Hawaii...Professor Jorgen Ekstrm is the recipient of the 2004 Salivary Research Award from the International Association for Dental Research (IADR), convening here today for its 82nd General Session. The award was designed to stimulate and recognize outstanding and innovative achievements that have contributed to the basic understanding of salivary gland structure, secretion, and function, or salivary composition and function.

Professor Ekstrm received his MD degree in 1966, and his PhD degree in physiology in 1975, from Lund University, Malm, Sweden. He now holds the positions of Professor and Chair in Pharmacology, Medical Faculty, Gteborg University, and Deputy Head of the Institute of Physiology and Pharmacology, Sahlgrenska Academy at Gteborg University, Sweden. He is a member of several major research associations and societies, and has served as Editor of the Journal of Physiology and other research publications. He has published 136 research papers, as well as reviews, book chapters, proceedings, and a patent.

Professor Ekstrm has dedicated his scientific career to unraveling the mysteries of autonomic nerve activities in salivary glands, thereby contributing to the understanding of the control of salivary secretion and related functions. He has made outstanding original contributions to these fields of enquiry. He commenced his research career in 1967 as a PhD student in the laboratory of Professor Emmelin at Lund University. Over the years, salivary glands served as the primary model organ in his studies aimed at gaining insight into autonomic neurotransmission mechanisms and their plasticity, and into how these mechanisms exert short-term effects (secretion and blood flow) as well as long-term effects (receptor sensitivity, metabolism and growth) on the glands.

His work has taken him into the realms of the interactions between the different nerves in salivary glandular function and to the effects of denervations, no
'"/>

Contact: Linda Hemphill
linda@iadr.org
International & American Association for Dental Research
10-Mar-2004


Page: 1 2 3

Related medicine news :

1. 2005 Salivary Research Award
2. Researchers search for first sign of congestive heart failure
3. Research offers hope of new treatments for liver damage
4. Research suggests possible blood test for multiple sclerosis
5. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
6. 2005 Award for Basic Research in Biological Mineralization
7. 2005 Craniofacial Biology Research Award
8. 2005 Research in Dental Caries Award
9. 2005 Research in Prosthodontics and Implants Award
10. 2005 Basic Research in Periodontal Disease Award
11. 2005 Research in Oral Biology Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Salivary Research Award Ekstrom

(Date:8/31/2015)... ... August 31, 2015 , ... ... at Monmouth, was one of the first doctors in the area to perform ... new approach have been impressive: faster recovery, decreased immediate and long-term pain, and ...
(Date:8/31/2015)... ... ... Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as an ... from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity letters ... senior year. He was inducted into the National Honor Society as a sophomore, was ...
(Date:8/31/2015)... ... 31, 2015 , ... With the FCPX LUT Soft pack from Pixel Film Studios, editors can ... that contains a mathematical formula for modifying an image. The LUT changes every pixel's color ... LUT files. , FCPX LUT Soft requires Final Cut Pro X 10.2 or newer. ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can healthcare meet the ... costs? , In a commentary for The American Journal of Managed Care ... “clinical efficacy,” which would bind parties together in agreements to intervene at the ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of diseases of the central nervous system ... submission has passed review by the US Food and ... 1 clinical trial in patients with metastatic colon cancer ... 31 December 2015. Bionomics, CEO & Managing ...
(Date:8/30/2015)... ANDOVER, Massachusetts y LONDRES, August 30, 2015 ... conectada ofrece una visión holística de l ... de todo el trayecto   ... anunciado hoy el debut europeo de IntelliSpace Cardiovascular ... información que ofrece sofisticadas herramientas para acceder, analizar y ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
Cached News: